Feasibility Study of the World Health Organization Health Care Facility-Based Antimicrobial Stewardship Toolkit for Low- and Middle-Income Countries
Autor: | Linda Kaljee, Sarah Paulin, Tyler Prentiss, Ingrid Smith, Gina Maki, Jessie Mlotha, Marcus J. Zervos, Watipaso Kasambara, Eliaser Johnson, Priscilla Rupali, Pem Chuki, Lisa Barrow, Deepak Bajracharya, Dipendra Raman Singh |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Microbiology (medical) 030106 microbiology barriers and enablers Context (language use) Asset (computer security) Biochemistry Microbiology World health Article 03 medical and health sciences 0302 clinical medicine Health care Hardware_INTEGRATEDCIRCUITS Antimicrobial stewardship Pharmacology (medical) 030212 general & internal medicine antimicrobial resistance low- and middle-income countries General Pharmacology Toxicology and Pharmaceutics Medical prescription Medical education business.industry lcsh:RM1-950 antimicrobial stewardship lcsh:Therapeutics. Pharmacology Infectious Diseases Low and middle income countries business Qualitative research Hardware_LOGICDESIGN |
Zdroj: | Antibiotics Antibiotics, Vol 9, Iss 556, p 556 (2020) Volume 9 Issue 9 |
ISSN: | 2079-6382 |
Popis: | Antimicrobial stewardship (AMS) has emerged as a systematic approach to optimize antimicrobial use and reduce antimicrobial resistance. To support the implementation of AMS programs, the World Health Organization developed a draft toolkit for health care facility AMS programs in low- and middle-income countries. A feasibility study was conducted in Bhutan, the Federated States of Micronesia, Malawi, and Nepal to obtain local input on toolkit content and implementation of AMS programs. This descriptive qualitative study included semi-structured interviews with national- and facility-level stakeholders. Respondents identified AMS as a priority and perceived the draft toolkit as a much-needed document to further AMS program implementation. Facilitators for implementing AMS included strong national and facility leadership and clinical staff engagement. Barriers included lack of human and financial resources, inadequate regulations for prescription antibiotic sales, and insufficient AMS training. Action items for AMS implementation included improved laboratory surveillance, establishment of a stepwise approach for implementation, and mechanisms for reporting and feedback. Recommendations to improve the AMS toolkit&rsquo s content included additional guidance on defining the responsibilities of the committees and how to prioritize AMS programming based on local context. The AMS toolkit was perceived to be an important asset as countries and health care facilities move forward to implement AMS programs. |
Databáze: | OpenAIRE |
Externí odkaz: |